DTx Europe Agenda

Download the Agenda

Conference Day 1

  • Wednesday, 14th July
Wednesday, 14th July
8:00am BST

Conference Platform Opens

The conference platform opens before the agenda starts, giving you time to plug the presentations, panels and discussions into your agenda for the rest of the day. This also gives you plenty of time to get familiar with the platform.

9:00am BST

Chair’s Opening Remarks and Setting the Scene

Maroof Ahmed, Co-Founder & COO, Quit Genius 

9:05am BST

Keynote Panel Discussion: Creating Reliable Top-Down Reimbursement for Digital Therapeutics 

As digital therapeutics continue to accelerate through their lifecycle, the requirement for top-down government reimbursement is paramount. This panel of experts, using current reimbursement systems as examples, will explore what the future of national DTx reimbursement will look like.

  • Is reimbursement on a national level across countries within Europe the next steps for DTx reimbursement?
  • What have we learnt from Germany’s DVG over the past year and how can this help for the development of national reimbursement in other countries?
  • An insight into Belgium’s new mHealth act for digital health reimbursement
  • What will it take for national reimbursement to be seen across most countries in Europe?
  • What can we expect to see for European DTx reimbursement in the next five years?

Nick Schneider, Head of Division 511, New Technologies & Data Use, German Federal Ministry of Health

Lord James Bethell, Parliamentary Under Secretary of State, Minister for Innovation, Government of the United Kingdom, Department of Health and Social Care

9:50am BST

Wellness Break

Get up and have a stretch before the next session begins.

9:55am BST

Presentation: Overview of European HTA Analysis 

  • Insight into DTx Health Technology Assessment by the Digital Therapeutics Alliance
  • What are market access commonalities in these 27 countries?
  • How big is the European market, really?

Jessica Shull, European Lead, Digital Therapeutics Alliance

10:20am BST

Speed Networking

In the purpose-built Networking area, get ready to expand your network through randomly assigned 1 on 1 quick-fire video meetings. You can choose who you want to “connect” with and then set-up 1-2-1 in-depth catch-ups throughout the rest of the event. 

This function also ensures that you don’t meet the same person more than once, allowing you to meet as many fellow attendees as you desire.

Your future collaborators or partners could be just one click away!

11:00am BST

Presentation: Rebalancing Digital Therapeutics in a Post-Pandemic Healthcare System

Throughout 2020 and into 2021, the digital therapeutics has seen monumentous growth alongside new schemes for reimbursement and regulation as a result of pandemic pressures. As we begin to look ahead, what will the healthcare system look like for digital therapeutics in a post-pandemic system?

  • What changes to the digital therapeutics industry are likely to stay once we come out of the pandemic?
  • With the requirement for remote-patient care likely reducing, what will this mean for digital therapeutics?
  • What does the industry need to do to ensure we stay on this upward trend?

Omar Manejwala, Chief Medical Officer, Dario Health 

11:25am BST

Wellness Break

Get-up and have a stretch before the next session begins.

11:30am BST

Presentation by Novartis

Representative from Novartis

11:55am BST

Wellness Break

Get-up and have a stretch before the next session begins.

12pm BST

Panel Discussion: How can we Ensure Smooth Integration into a Clinician’s Workflow for Improved Patient Care?

With modern healthcare systems ever adapting to ensure provision of care is always optimal, adding new tools to a clinician’s toolbox can be fairly routine. However, with digital therapeutics providing a novel approach of patient care, integration can demonstrate additional challenges. This panel will dive into exactly what clinicians think of DTx and how it fits into their current workflow.

  • What do clinicians really think of using digital therapeutics for patient care?
  • Do healthcare providers believe that DTx will become a part of their daily workflow?
  • What reservations about DTx are there 
  • Can digital therapeutics maintain high quality patient care remotely? 
  • What will it take for you to utilise digital therapeutics as you would a traditional therapeutics?

Visa Honkanen, Chief Digital Officer, Helsinki University Hospital 

Niklas Best, Director, Digital Ecosystems, Fresenius Medical Care 

Adam Dicker, SVP, Enterprise Radiation Oncology, Thomas Jefferson University Hospitals  

12:45pm BST

Lunch Break

2:00pm BST

Panel Discussion: Scaling Digital Therapeutics across Europe

Over recent years, digital therapeutics has seen huge growth internally throughout European countries. However, we are yet to see wide-spread success of a digital therapeutic across a high number of countries. This panel will discuss the intricacies of what it will take for DTx to scale across Europe.

  • What are the greatest challenges to scaling a digital therapeutics product across multiple markets in Europe?
  • How can we combat the cultural and language barriers to ensure smooth and effective integration?
  • Will streamlining European regulation for digital tools help scalability?
  • How can changes in the early development process of DTx help guarantee future scalability and growth?
  • Will we see an increase in digital therapeutics integration across multiple countries in Europe over the next 3 years?

Rachel Francine, Co-Founder & CEO, SingFit 

Nadar Alaghband, Chief Executive Officer, Ampersand Health

Tryggvi Thorgeirsson, Co-Founder & CEO, Sidekick Health 

Kai Eberhardt, Chief Executive Officer, Oviva

Caohime Vallely-Gilroy, Head of Digital Health & Therapeutics, Merck KGaA

2:50pm BST

Wellness Break

Catch-up on emails, let the dog out, brew some more coffee… use this time to take care of regular day-to-day life.

2:55pm BST

Presentation: Establishing Data Privacy and Security while maintaining Interoperability for Remote Patient Care

Data interoperability is paramount to ensure effective remote patient care. However, ensuring patient data privacy and security is a top priority. This presentation will dive into the intricacies of gaining patient trust through correct data privacy and security

  • How can we ensure data security and privacy when implementing remote patient care?
  • Ensuring patient data is protected and used in the right way
  • What ethical and governance frameworks are required to uphold effective data privacy?

Edward Bukstel, Lecturer, Thomas Jefferson University Hospital 

3:20pm BST

Wellness Break

Get up and have a stretch before the next session begins.

3:25pm BST

Fireside Chat: Building the ‘Right’ Partnership for Pharma & DTx 

Pharmaceutical & digital therapeutics partnerships have been at the forefront of the industry since the industry began. With a history of success stories and premature endings, what does it take to build out the right kind of partnership in this industry? This fireside chat, featuring leaders of the industry, will dive into how to create an effective and fruitful partnership

  • What should pharma companies and digital therapeutics companies be looking for in the right partner?
  • What can we learn from previous Pharma/DTx partnerships?
  • What are the benefits of creating Pharma/DTx Partnerships?
  • An insight into the partnerships created by the speakers of the session

Francesca Wuttke, Chief Digital Officer, Almirall

Ofer Leidner, Co-Founder & President, Happify Health 

4:10pm BST

Wellness Break

Get up and have a stretch before the next session begins.

4:15pm BST

Panel Discussion: What Impact can Digital Therapeutics have on the Healthcare System? 

Digital therapies are slowly becoming prevalent within mainstream health but what impact can digital tools actually have on healthcare? This panel of industry leaders will dive into exactly how digital therapeutics can help create a more efficient and effective healthcare system.

  • How can digital therapies increase the effectiveness and efficiency of healthcare?
  • What economic benefits can digital therapeutics have on the healthcare system?
  • Insights into how digital therapeutics can help HCP’s stay connected with patients outside of the clinic
  • What infrastructure is required to ensure digital therapeutics can securely impact the healthcare system?
  • A discussion into available patient usage, engagement and retention data DTx can provide to improve treatment

Kim Baden-Kristensen, Co-Founder & CEO, Brain+

Adam Higgins, Head of Digital Strategy, EMEA,  Johnson & Johnson

Edouard Gasser, Co-Founder & CEO, Tilak Healthcare

Jonathan Schreiber, Founder & CEO, Neuroventis

5:00pm BST

Chair’s Closing Remarks 

Maroof Ahmed, Co-Founder & COO, Quit Genius 

5:05pm BST

Virtual Drinks Reception

Share a virtual drink with old friends or new connections. At small virtual tables, this is your chance to casually interact with the rest of the Digital Therapeutics industry.

6pm BST

End of DTx Europe Day 1

Download the Agenda

Conference Day 2

  • Thursday, 15th July
Thursday, 15th July
8:00am BST

Conference Platform Opens

The conference platform opens an hour before the sessions begin so that you can plug the presentation, panels and discussions into your calendar for the day ahead.

9:00am BST

Chair’s Opening Remarks

Maroof Ahmed, Co-Founder & COO, Quit Genius 

9:05am BST

Panel Discussion: Understanding the Digital Strategy of healthcare Systems and Health Plans

Digital therapeutics are now demonstrating increased patient adoption, clinical outcomes and engagement. However, for DTx to scale, it’s important to understand the perspective and digital strategy of the organisations who can create ROI and deliver the therapeutic into the hands of the patient. 

  • A discussion into digital strategies for 2021 or beyond
  • Are digital therapeutics on the radar for health plans, employers and healthcare systems?
  • What can the digital therapeutics industry do to help educate and demonstrate the value of digital tools to these stakeholders?
  • What reservations are there for digital therapeutics, if any?
  • What infrastructure needs to be put in place to help the implementation and effectiveness of digital tools?

Ali Hasan, Chief Medical & Healthcare Officer, Vitality

More Speakers to Be Announced

9:50am BST

Wellness Break

Get up and have a stretch before the next session begins.

9:55am BST

Presentation: Case Study Presentation by Curio

  • An introduction to Curio, a digital therapeutics company developing tailor-made therapeutic solutions for women across the cycle of life.
  • An in-depth look at Curio’s recent RCT results.
  • What’s next for Curio?

Shailja Dixit, Founder & CEO, Curio

10:20am BST

Wellness Break

Get up and have a stretch before the next session begins.

10:25am BST

Presentation: A Deep-Dive Neuroventis – One Integrated Solution for Multiple Neurological Conditions

  • A deep dive into Neuroventis’ digital therapeutics for multiple neurological conditions
  • An insight into developing a multi-pathology digital therapy
  • What are the future plans for Neuroventis? 

Jonathan Schreiber, Founder & CEO, Neuroventis

10:50am BST

Wellness Break

Get up and have a stretch before the next session begins.

10:55am

Presentation:  Inflow Deep Dive – Using Digital Therapy to Support Neurodiversity

  • How can digital therapy support neurodiversity?
  • An introduction to Inflow; a digital program to better manage ADHD
  • What’s next for Inflow?

Sebastian Isaacs, Co-Founder, Inflow

11:20am

Wellness Break

Get up and have a stretch before the next session begins.

11:25am BST

Presentation: Case Study Presentation by GAIA AG

Matthias Zenker, Partner, GAIA AG

11:50am BST

Wellness Break

Get up and have a stretch before the next session begins.

11:55am BST

Panel Discussion: What is Going to Define the Success of the Industry Moving Forward?

Digital Therapeutics continued on their upward trend through 2020 and into 2021 under the pressures of the pandemic. However, there are a number of challenges still yet unanswered that will ensure the success of the industry. This panel will dive into what exactly will define the success of the industry.

  • What can the digital therapeutics industry do to ensure the future success of the industry?
  • What industry stakeholders can make the biggest difference in the space right now?
  • How can industry-wide collaboration benefit the industry moving forward?
  • How can we develop the right business models to ensure commercial success?
  • In a few sentences, what will define the success of the industry moving forward?

Anand Iyer, Chief Strategy Officer, Welldoc

Matthias Zenker, Partner, GAIA AG

Elcie Chan, EU Commercial Director, Otsuka Pharmaceutical Europe

Kristian Ranta, Founder & CEO. Meru Health

12:35pm BST

Chair’s Closing Remarks 

Maroof Ahmed, Co-Founder & COO, Quit Genius 

End of DTx Europe 2021

Download the Agenda